Geode Capital Management’s LianBio American Depositary Shares LIAN Stock Holding History

Geode Capital Management’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,027	Closed	-$112K	–	4661
2023 Q4	$112K	Buy	25,027 +5,533	+28%	+$19K	﹤0.01%	4149
2023 Q3	$29K	Hold	19,494	–	–	﹤0.01%	4546
2023 Q2	$44.4K	Buy	19,494 +4,000	+26%	+$9.2K	﹤0.01%	4532
2023 Q1	$30.2K	Buy	+15,494	New	+$32.1K	﹤0.01%	4632

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Geode Capital Management's LIAN Position: Q1 2024 in Review

Geode Capital Management sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 25,027 shares — an estimated $112K sold.

Geode Capital Management first reported a position in LIAN in Q1 2023 and held it in 4 quarters. The position peaked at $112K in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Geode Capital Management reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Geode Capital Management sold 25,027 LianBio American Depositary Shares shares in Q1 2024, an estimated $112K.
Geode Capital Management first reported a position in LianBio American Depositary Shares in Q1 2023 and held it in 4 quarters.
Geode Capital Management's LianBio American Depositary Shares position peaked at $112K in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.